search     
   You are here:  Home     July 1, 2015
 JOB OPPORTUNITIES


    

National Pediatric Sleep Groups   
News and activities from Pediatric Sleep Groups all over the world
  

Pediatric Sleep
  

Publications   
  

IPSA suggestions   
help us to make IPSA more complete and useful, send information about pediatric sleep activities in Your country.
  

IPSA CONGRESS.   
IPSA Congress 2016 - Taiwan March 11-13, 2016
Dear Friends, On behalf of the organizing committee, we are extremely happy to invite you to participate in the
IV International Pediatric Sleep Association Congress (IPSA 2016) which will be held on March 11-13, 2016, in Taipei International Convention Center, located in the heart of Taipei, Taiwan.

We sincerely hope the beauty of our city and the theme of our conference will attract you all. The IPSA 2016 serves as a premier event on the international calendar of pediatric sleep bringing together physicians, educators, basic scientists, sleep technician and clinical investigators from hospitals, industry, and academia to present and share the latest cutting-edge research results and innovative solutions in the related fields. We believe you will have a fruitful and enjoyable time during your stay in Taipei based on our solid program and the hospitality of Taipei, Taiwan aka “Formosa”.(“beautiful in Portuguese”) island, as used by the Portuguese mariners centuries ago to describe Taiwan Look forward to seeing you in Taipei, Taiwan in 2016! Best Regards, Dr. Yu-Shu Huang, Chair of IPSA 2016 and Local Organizer Dr. Daniel KK Ng, Co-Chair of IPSA 2016 Dr. Oliviero Bruni, President of IPSA Dr. Chia-Mo Lin, President of Taiwan Society of Sleep Medicine   read more...

IPSA Congress 2014 - Porto Alegre - Brazil - Sunday, September 29, 2013

It is my pleasure to present the
III Congress of the International Pediatric Sleep Association (IPSA) - Porto Alegre (Brazil) 3-5 December 2014.

The importance of sleep for health, learning and psychomotor development in infancy, childhood and adolescence has been emphasized in the pediatric research in the last two decades and it has become more and more evident that ensuring a good sleep during development is of key importance for a later healthy life.
The IPSA Congress is an influential forum for sleep practitioners from around the world to network and exchange views, whilst learning from world-class researchers about the latest scientific and clinical developments in the field.
The success of the last two Congresses in Rome 2010 and Manchester 2012 has highlighted the magnitude of Pediatric Sleep Medicine in the scientific community and we hope that the 2014 Congress will provide a perfect balance between didactic and practical needs, in order to provide the technical knowhow and up-to-date knowledge that will enable participants to improve their practice.
As traditional for IPSA, the most renowned International opinion leaders in the field of Pediatric Sleep Medicine speakers will join the Congress and will highlight the recent significant advances in both basic science and clinical sleep medicine during development.
I hope that the world paediatric sleep community will gather together in the lively city of Porto Alegre to celebrate the best clinical practice and the latest advances in Pediatric Sleep Medicine.

Oliviero Bruni
President of the International Pediatric Sleep Association

  read more...

IPSA Congress 5-7 december 2012 - Manchester City (UK)

IPSA Congress 5-7th December 2012 - Manchester (UK)   read more...

ABSTRACT BOOK OF THE IPSA CONGRESS, Rome 3-5 December 2010

IPSA 2010 - Abstract Book

  read more...

  

 Announcements

Guia SAOS Infantil Espanola

New guidelines on the diagnosis and treatment of OSA in children published by the Spanish Pediatric Sleep Group. (available only in Spanish)

  read more...


    

RECENT LITERATURE HIGHLIGHTS   
[PageLinks]     TIP: Press shift while clicking on the article to open in a new window.

Biomarkers in volunteers exposed to mobile phone radiation.
Related Articles

Biomarkers in volunteers exposed to mobile phone radiation.

Toxicol Lett. 2015 Jun 1;235(2):140-6

Authors: Söderqvist F, Carlberg M, Hardell L

Abstract
For some time it has been investigated whether low-intensity non-thermal microwave radiation from mobile phones adversely affects the mammalian blood-brain barrier (BBB). All such studies except one have been either in vitro or experimental animal studies. The one carried out on humans showed a statistically significant increase in serum transthyretin (TTR) 60 min after finishing of a 30-min microwave exposure session. The aim of the present study was to follow up on the finding of the previous one using a better study design. Using biomarkers analyzed in blood serum before and after the exposure this single blinded randomized counterbalanced study, including 24 healthy subjects aged 18-30 years that all underwent three exposure conditions (SAR(10G)=2 W/kg, SAR(10G)=0.2 W/kg, sham), tested whether microwaves from an 890-MHz phone-like signal give acute effects on the integrity of brain-shielding barriers. Over time, statistically significant variations were found for two of the three biomarkers (TTR; β-trace protein); however, no such difference was found between the different exposure conditions nor was there any interaction between exposure condition and time of blood sampling. In conclusion this study failed to show any acute clinically or statistically significant effect of short term microwave exposure on the serum levels of S100β, TTR and β-trace protein with a follow up limited to two hours. The study was hampered by the fact that all study persons were regular wireless phone users and thus not naïve as to microwave exposure.

PMID: 25839137 [PubMed - indexed for MEDLINE]


Variants in Solute Carrier SLC26A9 Modify Prenatal Exocrine Pancreatic Damage in Cystic Fibrosis.
Related Articles

Variants in Solute Carrier SLC26A9 Modify Prenatal Exocrine Pancreatic Damage in Cystic Fibrosis.

J Pediatr. 2015 May;166(5):1152-1157.e6

Authors: Miller MR, Soave D, Li W, Gong J, Pace RG, Boëlle PY, Cutting GR, Drumm ML, Knowles MR, Sun L, Rommens JM, Accurso F, Durie PR, Corvol H, Levy H, Sontag MK, Strug LJ

Abstract
OBJECTIVES: To test the hypothesis that multiple constituents of the apical plasma membrane residing alongside the causal cystic fibrosis (CF) transmembrane conductance regulator protein, including known CF modifiers SLC26A9, SLC6A14, and SLC9A3, would be associated with prenatal exocrine pancreatic damage as measured by newborn screened (NBS) immunoreactive trypsinogen (IRT) levels.
STUDY DESIGN: NBS IRT measures and genome-wide genotype data were available on 111 subjects from Colorado, 37 subjects from Wisconsin, and 80 subjects from France. Multiple linear regression was used to determine whether any of 8 single nucleotide polymorphisms (SNPs) in SLC26A9, SLC6A14, and SLC9A3 were associated with IRT and whether other constituents of the apical plasma membrane contributed to IRT.
RESULTS: In the Colorado sample, 3 SLC26A9 SNPs were associated with NBS IRT (min P=1.16×10(-3); rs7512462), but no SLC6A14 or SLC9A3 SNPs were associated (P>.05). The rs7512462 association replicated in the Wisconsin sample (P=.03) but not in the French sample (P=.76). Furthermore, rs7512462 was the top-ranked apical membrane constituent in the combined Colorado and Wisconsin sample.
CONCLUSIONS: NBS IRT is a biomarker of prenatal exocrine pancreatic disease in patients with CF, and a SNP in SLC26A9 accounts for significant IRT variability. This work suggests SLC26A9 as a potential therapeutic target to ameliorate exocrine pancreatic disease.

PMID: 25771386 [PubMed - indexed for MEDLINE]


Changes in the association between health complaint frequency and medicine use among adolescents in Scotland between 1998 and 2010.
Related Articles

Changes in the association between health complaint frequency and medicine use among adolescents in Scotland between 1998 and 2010.

J Psychosom Res. 2015 Apr;78(4):371-6

Authors: Levin KA, Whitehead R, Andersen A, Levin D, Gobina I, Holstein B

Abstract
OBJECTIVE: Medicines have the potential to cause harm, particularly when adolescents do not follow recommendations for use. In addition, medicine use in adolescence has been shown to track into adulthood. There is therefore a strong rationale to monitor changes in adolescent medicine use over time and understand the mechanisms behind these changes
METHODS: Data from the 1998, 2006 and 2010 Scotland Health Behaviour in School-aged Children Survey were modelled using multilevel logistic regression, modelling medicine use for: headache, stomachache, sleeping difficulties and nervousness, as well as a combined medicine use measure. Models adjusted for year and frequency of health complaints to measure trends in medicine use, and an interaction term to measure the relationship between medicine use and health complaint frequency.
RESULTS: Medicine use reduced between 1998 and 2010. Hownever having the majority of the reduction was observed between 1998 and 2006 for all five outcomes. Adjustment for health complaint frequency only explained some of this reduction. When an interaction term was added between year and health complaint frequency this was significant for boys' medicine use, suggesting that health complaint frequency became a better predictor of medicine use with time. Medicine use for stomachache among girls increased over time, and this increase became more pronounced after adjustment for stomachache frequency.
CONCLUSION: Changes in health complaint frequency were only partly associated with reductions in medicine use between 1998 and 2010. Further monitoring of medicine use is recommended, particularly the use of medicine for sleep difficulties, and for stomachache among girls.

PMID: 25582801 [PubMed - indexed for MEDLINE]

[PageLinks]
     

Join IPSA. It's free!!!   
Join IPSA
Just add Your data to the membership module   read more...
  

Upcoming Meetings   
  

PEDIATRIC SLEEP COURSES   
  

Home|IPSA Mission|Board|Bylaws|Contact IPSA|Membership|Site Map
Copyright (c) 2015 IPSA Terms Of Use Privacy Statement